https://www.selleckchem.com/pr....oducts/glycochenodeo
Drug safety is generally established from clinical trials, by pharmacovigilance programs and during observational Phase IV safety studies according to drug intended or approved indications. The objective of this study was to estimate the risk of potential adverse drug events (ADE) associated with drugs repurposed for COVID-19 treatment in a large-scale population. Drug claims were used to calculate a baseline medication risk score (MRS) indicative of ADE risk level. Fictitious claims of repurposed drugs were added, on
Like
Comment
Share
